Amicus Therapeutics (FOLD)
(Delayed Data from NSDQ)
$9.66 USD
+0.16 (1.68%)
Updated Nov 22, 2024 03:57 PM ET
After-Market: $9.88 +0.22 (2.28%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 2/26/25 |
---|---|
Current Quarter | 0.10 |
EPS Last Quarter | 0.10 |
Last EPS Surprise | 25.00% |
ABR | 1.31 |
Earnings ESP
|
-2.63% |
---|---|
Current Year | 0.23 |
Next Year | 0.49 |
EPS (TTM) | 0.03 |
P/E (F1) | 41.91 |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 146.15M | 142.43M | 523.27M | 632.63M |
# of Estimates | 6 | 5 | 6 | 6 |
High Estimate | 148.45M | 146.47M | 527.04M | 651.61M |
Low Estimate | 143.66M | 139.18M | 513.42M | 617.69M |
Year ago Sales | 115.08M | 110.40M | 399.36M | 523.27M |
Year over Year Growth Est. | 27.00% | 29.01% | 31.03% | 20.90% |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.10 | 0.07 | 0.23 | 0.49 |
# of Estimates | 6 | 5 | 6 | 6 |
Most Recent Consensus | 0.02 | NA | 0.13 | 0.36 |
High Estimate | 0.16 | 0.11 | 0.30 | 0.66 |
Low Estimate | 0.02 | 0.04 | 0.13 | 0.34 |
Year ago EPS | -0.11 | -0.02 | -0.51 | 0.23 |
Year over Year Growth Est. | 190.91% | 450.00% | 145.10% | 113.77% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 3 | 2 | 2 | 0 |
Up Last 60 Days | 4 | 3 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 2 | 4 |
Down Last 60 Days | 1 | 0 | 2 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.10 | 0.07 | 0.23 | 0.49 |
7 Days Ago | 0.10 | 0.07 | 0.23 | 0.49 |
30 Days Ago | 0.10 | 0.07 | 0.22 | 0.53 |
60 Days Ago | 0.08 | 0.07 | 0.20 | 0.49 |
90 Days Ago | 0.09 | 0.06 | 0.20 | 0.48 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.09 | 0.10 | 0.23 | 0.45 |
Zacks Consensus Estimate | 0.10 | 0.07 | 0.23 | 0.49 |
Earnings ESP | -2.63% | 35.14% | 2.57% | -7.85% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.10 | 0.06 | -0.02 | -0.11 | NA |
Estimate | 0.08 | 0.03 | -0.06 | -0.06 | NA |
Difference | 0.02 | 0.03 | 0.04 | -0.05 | 0.01 |
Surprise | 25.00% | 100.00% | 66.67% | -83.33% | 27.09% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more